|
Market Cap (10-Jun) $47,863,656 (0th) |
Close (30-Jun) $0.85 |
Volume (30-Jun) 942,590 |
Shortsold (27-Oct) 800,001 (0.58%) (257th) |
|
52w High $0.490 |
52w Low $0.312 |
P/E - |
EPS -0.06 |
IIQ released this announcement to the ASX on 7 March 2023, 9:08. The announcement is not marked as price sensitive, and is 2 page(s) in length and 199.45kb in size.
You can view all announcements from IIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, IIQ was 0.004% short sold according to ASIC data. It was ranked the 613th most shorted stock on the ASX. It is now ranked as the 257th most shorted stock on the ASX with 0.576% of total shares short sold as of the latest reported data (27 October 2025).
| Other Recent Announcements from IIQ | |
|---|---|
| Notification of cessation of securities - IIQ | 30 June 2023, 14:19 |
| SubB2M/CA15.3 Clinical Validation Data Investor Presentation | 29 June 2023, 10:48 |
| INOVIQ Investor Briefing | 27 June 2023, 14:07 |
| Change of Director's Interest Notice - Philip Powell | 7 March 2023, 9:08 |
| Change of Director's Interest Notice - Philip Powell | 6 March 2023, 9:23 |
| Appendix 4D and Half Year Financial Report | 24 February 2023, 9:15 |
| Positive results for SubB2M Breast Cancer Test | 8 February 2023, 10:02 |
You must be logged in to post a reply.
